Schedule 13D ownership disclosure

APPLIED THERAPEUTICS INC

Security class unavailable · CUSIP: 03828A101

Event date: 2022-10-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,570,835
Percent of class
14.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001341004-22-000275
Form type
SC 13D/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Oct 14, 2022
Reporting period
Oct 12, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub